• FOLLOW US
Video Player
  • Email
  • share

Boston Therapeutics' New Tablet Reduces Sugar Intake for Diabetics

Boston Therapeutics has a new tablet PAZ320 designed to reduce a person's sugar intake by 40%. CEO Dr. David Platt believes the tablet will eventually be approved for non-diabetic patients looking to cut back on the copious amounts of sugar prevalent

http://www.wgrz.com/video/2952005903001/1/Boston-Therapeutics-New-Tablet-Reduces-Sugar-Intake-for-Diabetics http://cdn.newslook.com/28/2816a8d81c4fcd18aaa94a16d5a3edd4/images/frame_0011.jpg Boston Therapeutics' New Tablet Reduces Sugar Intake for Diabetics Boston Therapeutics has a new tablet PAZ320 designed to reduce a person's sugar intake by 40%. CEO Dr. David Platt believes the tablet will eventually be approved for non-diabetic patients looking to cut back on the copious amounts of sugar prevalent FinancenewslookHealthBoston Therapeutics 02:56

Next Up

    

More Videos